{
  "ticker": "PCVX",
  "company_name": "Vaxcyte, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT05266456",
      "title": "Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Adults",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Pneumococcal Vaccines",
      "start_date": "2022-02-22",
      "completion_date": "2023-01-10",
      "enrollment": 0,
      "sponsor": "Vaxcyte, Inc."
    },
    {
      "nct_id": "NCT06151288",
      "title": "Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Pneumococcal Vaccines",
      "start_date": "2023-11-08",
      "completion_date": "2024-07-17",
      "enrollment": 0,
      "sponsor": "Vaxcyte, Inc."
    },
    {
      "nct_id": "NCT05844423",
      "title": "Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infants",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Pneumococcal Vaccines",
      "start_date": "2023-03-29",
      "completion_date": "2025-08-25",
      "enrollment": 0,
      "sponsor": "Vaxcyte, Inc."
    },
    {
      "nct_id": "NCT07365826",
      "title": "A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults \u2265 50 Years of Age",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Pneumococcal Vaccines",
      "start_date": "2026-01-12",
      "completion_date": "2027-03",
      "enrollment": 0,
      "sponsor": "Vaxcyte, Inc."
    },
    {
      "nct_id": "NCT07284654",
      "title": "Safety, Tolerability, and Immunogenicity of VAX-31 in Adults \u226550 Years With Immunobridging to Adults 18-49",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Pneumococcal Vaccines",
      "start_date": "2025-12-01",
      "completion_date": "2027-01",
      "enrollment": 0,
      "sponsor": "Vaxcyte, Inc."
    },
    {
      "nct_id": "NCT05297578",
      "title": "Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adults",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Pneumococcal Vaccines",
      "start_date": "2022-06-15",
      "completion_date": "2023-02-15",
      "enrollment": 0,
      "sponsor": "Vaxcyte, Inc."
    },
    {
      "nct_id": "NCT06720038",
      "title": "A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Pneumococcal Vaccines",
      "start_date": "2024-11-25",
      "completion_date": "2027-12",
      "enrollment": 0,
      "sponsor": "Vaxcyte, Inc."
    }
  ],
  "summary": {
    "total_trials": 7,
    "by_phase": {
      "PHASE1, PHASE2": 2,
      "PHASE2": 3,
      "PHASE3": 2
    },
    "by_status": {
      "COMPLETED": 4,
      "RECRUITING": 2,
      "ACTIVE_NOT_RECRUITING": 1
    },
    "active_trials": 3,
    "completed_trials": 4,
    "conditions": [
      "Pneumococcal Vaccines"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:20:51.431718",
    "search_query": "Vaxcyte, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Vaxcyte,+Inc."
  }
}